课题基金 / 基金详情

RANDOMIZED TRIAL OF PROTEASE INHIBITOR-INCLUDING VS. PRO

RANDOMIZED TRIAL OF PROTEASE INHIBITOR-INCLUDING VS. PRO
含蛋白酶抑制剂与含蛋白酶抑制剂的随机试验
批准号：
7042126
负责人：
MARGARET A KELLER
金额：
$0.39万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2003
资助国家：
美国
项目状态：
已结题
起止时间：
2003-12-01 至 2004-11-30
来源：
https://reporter.nih.gov/project-details/7042126
关键词：
HIV infectionsantiAIDS agentclinical researchcombination chemotherapydrug screening /evaluationfemalehuman pregnant subjecthuman therapy evaluationlamivudinemicroorganism disease chemotherapynelfinavirnevirapinepatient oriented researchpharmacokineticspostpartumpregnancyprotease inhibitorreverse transcriptase inhibitorswomen&aposs healthzidovudine

项目成果

MARGARET A KELLER的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS HIV
INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL DRUG COMBINATIONS
Two-Dimensional 3 Tesla MRS of the Brain in HIV- Infected Youth
PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL THERAPY DURING PREGNANCY
海外基金